Paul Davie

BIOVIA, Inc. develops and commercializes scientific informatics software products and services for industries and organizations that rely on scientific innovation. Its enterprise platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. The company by incorporating its capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, it enables scientific innovators to access, organize, analyze and share data in various ways. BIOVIA was founded in 1993 and is headquartered in San Diego, CA.

InforSense provides a suite of highly agile, predictive and visual enterprise business intelligence and reporting software. InforSense was founded in 1999 to commercialize pioneering, award-winning technology in the fields of High Performance Computing and Large Scale Data Mining developed at Imperial College, London. InforSense is a private company based in London, UK with additional offices in Cambridge, MA, USA and Shanghai, China. InforSense's core expertise lies in the development of a generic, horizontal, high performance business and scientific intelligence and Web-based reporting platform. This platform enables organizations to integrate, automate and visualize data sources, information and analysis processes to deliver significantly improved productivity, performance and breakthrough predictive insights. InforSense goes beyond traditional business intelligence by enabling predictive analytics from a variety of data and text sources to be embedded into any third party application software or hardware, and delivered to users entirely over the Web.

Oxford Drug Design Ltd. develops application of new technologies to drive computer-aided drug discovery. It specializes in drug discovery, molecular modeling, lead identification and optimisation, formulation modeling and preclinical studies. The company was founded by W. Graham Richards in 2001 and is headquartered in Oxford, the United Kingdom.

Dassault Systemes Biovia Ltd. provides software for computation, simulation, and the management and mining of scientific data used by biologists, chemists and materials scientists, including nanotechnology researchers, for product design as well as drug discovery and development. The company was founded on December 7, 1988 and is headquartered in Cambridge, the United Kingdom.

Secerno is the technology leader in data security and control. Its UK headquarters are in Oxford and its US headquarters in New York, New York. Its Secerno DataWall solutions are the new approach to controlling how data in databases is accessed. Secerno DataWall includes database activity monitoring, real-time data protection and data auditing and compliance solutions available as a range of either hardware or virtual appliances on the VMware platform. With Secerno DataWall, the company enables the organizations to stop database threats before data is lost or compromised (instead of simply monitoring and reporting after the damage is done). It accurately and actively blocks all threats to its customer's data, even from trusted and privileged users. It offers the highest levels of protection against these threats and optimizes compliance auditing, as well as delivering the ability to improve the security of applications. At the core of Secerno DataWall is the patented SynoptiQ Engine, based on break-through research into efficient grammatical clustering undertaken at the Oxford University Computing Laboratory. The SynoptiQ Engine uses Semantic Clustering to cluster queries automatically and intelligently into an Intent-Based Model of database environments. They are distilled into meaningful information for efficient human review and automatic generation of a zero-defect database policy that identifies with fine precision and total accuracy every kind of query that is allowed to reach each database - and specifies the actions to be taken on out-of-policy activity.

The Cambridge Crystallographic Data Centre, founded in 1965, is a non-profit company that specializes in providing support and licensing for their CSD data and software. The company is based in Cambridge, UK and has subsidiaries in the United Kingdom. The British company's historical structures date back to the 1920s. The CS-Crossminer software allows users to build pharmacophore queries and mine the CS data simultaneously.